Dr. Reddy’s Laboratories shares fell by 6.2%, hitting an intraday low of Rs 1,209.70 on the BSE on Friday, January 24, following the release of its Q3 FY25 earnings report. The pharma major posted a ...

Dr. Reddy's Laboratories shares fell by 6.2% after the company reported a marginal 2% YoY growth in Q3 FY25 net profit to Rs 1,413 crore. Despite robust revenue growth, Jefferies, Nuvama, and DAM ...

UltraTech Cement, Dr Reddy’s Labs, Hindustan Petroleum, Mphasis, Zee, Indus Towers, Adani Green Energy, Adani Energy ...

Goldman Sachs reportedly has maintained a 'Buy' rating and increased its target price to Rs 12,580, up from Rs 12,460, citing volume recovery and lower costs contributing to margin improvement ...

Shares of firms like ICICI Bank, IndiGo, NTPC, UltraTech, Adani Wilmar, and others will be in focus on Friday's trade ...

The stock markets today will eye Q3 results of 81 domestic companies, Flash manufacturing PMI, IPOs, FII selling, and Budget ...

Ultratech Cement reported a 17% YoY decline in its net profit in the December quarter. Volume is was recorded at 10% YoY.

The company’s technology is essential for removing the heat generated by the computers training and operating generative AI models such as ChatGPT, according to Brain ...

EA stock is spiraling Thursday after video game maker Electronic Arts released preliminary quarterly numbers and lowered its full-year bookings guidance.

Thyrocare on Thursday announced its financial results for the quarter and nine months ended December 31, 2024.